Menu
Back to Journals » Cancer Management and Research » Volume 12
Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak
Authors Liu Y, Wang J, Tang Y, Su R, Yang Q
Received 15 April 2020
Accepted for publication 10 June 2020
Published 20 July 2020 Volume 2020:12 Pages 6053—6058
DOI https://doi.org/10.2147/CMAR.S258121
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Antonella D'Anneo
Yong Liu,1 Jiaming Wang,1 Yi Tang,1 Rong Su,1 Qianwen Yang2
1The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China, 510150; 2The University of Melbourne, Melbourne, Australia, 3052
Correspondence: Yong Liu
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, People’s Republic of China
Email dr13809207569@163.com
Abstract: In December 2019, a new coronavirus pneumonia began to break out globally. COVID-19 pandemic challenges the health systems worldwide and influences the treatments for other diseases. The incidence rate of breast cancer ranks first among all malignant tumors among women. During the pandemic, medical workers should strictly monitor the condition of patients and strengthen the management and prevention measures to make sure patients can be operated safely. This article will discuss the arrangements and management of surgical treatment for patients with breast cancer.
Keywords: COVID-19, pneumonia, breast cancer, surgery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.